Epithelial Antimicrobial Peptide/Protein and Cytokine Expression Profiles Obtained from Nasopharyngeal Swabs of SARS-CoV-2-Infected and Non-Infected Subjects.

COVID-19 RNase-7 S100A7 SALP/elafin SARS-CoV-2 antimicrobial peptides antimicrobial proteins coronavirus innate immunity pro-inflammatory cytokines psoriasin

Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
15 Sep 2024
Historique:
received: 12 08 2024
revised: 07 09 2024
accepted: 09 09 2024
medline: 29 9 2024
pubmed: 28 9 2024
entrez: 28 9 2024
Statut: epublish

Résumé

Immune responses of the epithelia of the upper respiratory tract are likely crucial in early inhibition of the viral replication and finally clearance of SARS-CoV-2. We aimed to compare the expression profiles of antimicrobial peptides/proteins (AMPs) and related cytokines observed in the nasopharynx of SARS-CoV-2-infected patients and non-infected controls and to assess the associations between these parameters and COVID-19 patients' outcomes. We included 45 subjects who had tested positive for SARS-CoV-2 and 22 control subjects who had tested negative for SARS-CoV-2. Biomaterial for SARS-CoV-2 detection, as well as gene and protein expression studies, was obtained from all subjects using nasopharyngeal swabs which were performed a maximum of 7 days before inclusion in the study. Univariable and multivariable statistics were performed. When compared to the controls, the mRNA expression levels of human β-defensin 1 (hBD-1), LL-37, and trappin-2 were significantly higher in specimens of nasopharyngeal swabs from COVID-19 patients. Protein expression of hBD-1 was also increased in the COVID-19 group. mRNA expression levels of interferon-ɣ (IFN-ɣ), tumor necrosis factor- ɑ (TNF-ɑ), and interleukin-6 (IL-6) measured in SARS-CoV-2-infected patients were significantly higher than those observed in the controls, which could also be confirmed in the protein levels of IFN-ɣ and IL-6. A significant correlation between mRNA and protein levels could be observed only for IL-6. Univariable analysis revealed that low IFN-ɣ mRNA levels were associated with severe/fatal outcomes. The occurrence of COVID-19 pneumonia was significantly associated with lower expression levels of IL-6 mRNA, IFN-ɣ mRNA, and TNF-ɑ mRNA. Concerning the severe/fatal outcomes, the multivariable logistic regression model revealed that none of the aforementioned parameters remained significant in the model. However, the logistic regression model revealed that higher TNF-ɑ mRNA expression was a significant independent predictor of absence of pneumonia [odds ratio: 0.35 (95% CI 0.14 to 0.88,

Identifiants

pubmed: 39339947
pii: v16091471
doi: 10.3390/v16091471
pii:
doi:

Substances chimiques

Cytokines 0
Antimicrobial Peptides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Thilo Gambichler (T)

Department of Dermatology, Ruhr-University Bochum, 44791 Bochum, Germany.
Department of Dermatology, Dortmund Hospital, Faculty of Health, School of Medicine, University Witten/Herdecke, 44137 Dortmund, Germany.
Department of Dermatology, Christian Hospital Unna, 59423 Unna, Germany.

Silke Goesmann (S)

Department of Dermatology, Ruhr-University Bochum, 44791 Bochum, Germany.

Marina Skrygan (M)

Department of Dermatology, Ruhr-University Bochum, 44791 Bochum, Germany.

Laura Susok (L)

Department of Dermatology, Ruhr-University Bochum, 44791 Bochum, Germany.
Department of Dermatology, Dortmund Hospital, Faculty of Health, School of Medicine, University Witten/Herdecke, 44137 Dortmund, Germany.

Christian Schütte (C)

Department of Internal Medicine, Ruhr-University Bochum, 44791 Bochum, Germany.

Nahza Hamdani (N)

Department of Molecular and Experimental Cardiology, Ruhr-University Bochum, 44791 Bochum, Germany.
Department of Cardiology, Ruhr-University Bochum, 44791 Bochum, Germany.
Institute of Physiology, Ruhr-University Bochum, 44801 Bochum, Germany.

Wolfgang Schmidt (W)

Department of Internal Medicine, Ruhr-University Bochum, 44791 Bochum, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH